Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Nov 20, 2017 UPLOAD UPLOAD
0000000000-17-040970.pdf
Nov 15, 2017 CORRESP CORRESP View HTML
0001193125-17-344459.pdf
0001193125-17-344459.rtf
0001193125-17-344459.xls
Nov 13, 2017 CORRESP CORRESP View HTML
0001193125-17-341009.pdf
0001193125-17-341009.rtf
Oct 27, 2017 DRS/A mendment to a previously filed DRS View HTML
0000950123-17-009295.pdf
0000950123-17-009295.rtf
0000950123-17-009295.xls
Oct 24, 2017 UPLOAD UPLOAD
0000000000-17-037628.pdf
Oct 13, 2017 DRS/A mendment to a previously filed DRS View HTML
0000950123-17-009028.pdf
0000950123-17-009028.rtf
0000950123-17-009028.xls
Oct 06, 2017 UPLOAD UPLOAD
0000000000-17-035598.pdf
Sep 08, 2017 DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy View HTML
0000950123-17-008432.pdf
0000950123-17-008432.rtf
0000950123-17-008432.xls
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 69
  • Page 70
  • Current page 71
Displaying 701 - 708 of 708 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use